Literature DB >> 1857134

The ethics of ongoing randomization trials. Investigation among intimates.

H I Goldberg1, H McGough.   

Abstract

Precisely because firm trials employ experimental designs, it is important that attention be paid to the rights and welfare of the human subjects of these evaluations. This report reviews how administrative firm trials, those that do not directly interfere in the practice of medicine, can be ethically conducted. However, because spiraling health costs are increasing pressures on managers to determine which medical practices are the most cost-effective, we also consider how clinical firm trials comparing accepted diagnostic or therapeutic modalities might be performed. Both of these types of trials require that patients agree to join clinical communities whose routine practice has been redefined to include some level of minimal-risk experimentation. Consequently, it may be appropriate for firm systems formally to adopt a new paradigm of investigation among intimates, one that encourages the participation of patients in all aspects of the research endeavor.

Entities:  

Mesh:

Year:  1991        PMID: 1857134

Source DB:  PubMed          Journal:  Med Care        ISSN: 0025-7079            Impact factor:   2.983


  3 in total

1.  Pitfalls of and controversies in cluster randomization trials.

Authors:  Allan Donner; Neil Klar
Journal:  Am J Public Health       Date:  2004-03       Impact factor: 9.308

2.  Conducting Clinical Research in Post-acute and Long-term Nursing Home Care Settings: Regulatory Challenges.

Authors:  Allison M Gustavson; Cynthia Drake; Alison Lakin; Andrea E Daddato; Jason R Falvey; Warren Capell; Hillary D Lum; Christine D Jones; Kathleen T Unroe; Gail L Towsley; Jennifer E Stevens-Lapsley; Cari R Levy; Rebecca S Boxer
Journal:  J Am Med Dir Assoc       Date:  2019-07       Impact factor: 4.669

3.  Hospital ward design and prevention of hospital-acquired infections: A prospective clinical trial.

Authors:  Jennifer Ellison; Danielle Southern; Donna Holton; Elizabeth Henderson; Jean Wallace; Peter Faris; William A Ghali; John Conly
Journal:  Can J Infect Dis Med Microbiol       Date:  2014-09       Impact factor: 2.471

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.